These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14748756)

  • 1. Diffusion of arylpropionate non-steroidal anti-inflammatory drugs into the cerebrospinal fluid: a quantitative structure-activity relationship approach.
    Péhourcq F; Matoga M; Bannwarth B
    Fundam Clin Pharmacol; 2004 Feb; 18(1):65-70. PubMed ID: 14748756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of molecular lipophilicity on the diffusion of arylpropionate non-steroidal anti-inflammatory drugs into the cerebrospinal fluid.
    Matoga M; Péhourcq F; Lagrange F; Tramu G; Bannwarth B
    Arzneimittelforschung; 1999 Jun; 49(6):477-82. PubMed ID: 10417861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of immobilized artificial membrane chromatography for lipophilicity determination of arylpropionic acid non-steroidal anti-inflammatory drugs.
    Pehourcq F; Jarry C; Bannwarth B
    J Pharm Biomed Anal; 2003 Sep; 33(2):137-44. PubMed ID: 12972078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lipophilicity on the diffusion of cephalosporins into the cerebrospinal fluid.
    Radouane A; Péhourcq F; Tramu G; Creppy EE; Bannwarth B
    Fundam Clin Pharmacol; 1996; 10(3):309-13. PubMed ID: 8836706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between lipophilicity and binding to human serum albumin of arylpropionic acid non-steroidal anti-inflammatory drugs.
    Deschamps-Labat L; Péhourcq F; Jagou M; Bannwarth B
    J Pharm Biomed Anal; 1997 Oct; 16(2):223-9. PubMed ID: 9408837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges.
    Nau R; Sörgel F; Prange HW
    J Neurol Sci; 1994 Mar; 122(1):61-5. PubMed ID: 8195805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of arylpropionic acidic non-steroidal anti-inflammatory drugs in pharmaceutical formulations and human plasma by HPLC with UV detection.
    Sun Y; Takaba K; Kido H; Nakashima MN; Nakashima K
    J Pharm Biomed Anal; 2003 Jan; 30(5):1611-9. PubMed ID: 12467933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a polymeric formulation of ketoprofen on its diffusion into cerebrospinal fluid in rats.
    Matoga M; Péhourcq F; Lagrange F; Fawaz F; Bannwarth B
    J Pharm Biomed Anal; 2002 Mar; 27(6):881-8. PubMed ID: 11836052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lipophilicity on in vivo iontophoretic delivery. I. NSAIDs.
    Tashiro Y; Shichibe S; Kato Y; Hayakawa E; Itoh K
    Biol Pharm Bull; 2001 Mar; 24(3):278-83. PubMed ID: 11256485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid.
    Bannwarth B; Netter P; Pourel J; Royer RJ; Gaucher A
    Biomed Pharmacother; 1989; 43(2):121-6. PubMed ID: 2660917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of lipophilicity of some non-steroidal anti-inflammatory agents and their relationships by using principal component analysis based on thin-layer chromatographic retention data.
    Sârbu C; Todor S
    J Chromatogr A; 1998 Oct; 822(2):263-9. PubMed ID: 9809446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical profile of nimesulide. Exploring the interplay of lipophilicity, solubility and ionization.
    Dellis D; Giaginis C; Tsantili-Kakoulidou A
    J Pharm Biomed Anal; 2007 May; 44(1):57-62. PubMed ID: 17336024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immobilized artificial membrane chromatography: quantitative structure-retention relationships of structurally diverse drugs.
    Luco JM; Salinas AP; Torriero AA; Vázquez RN; Raba J; Marchevsky E
    J Chem Inf Comput Sci; 2003; 43(6):2129-36. PubMed ID: 14632465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content.
    Montenegro L; Carbone C; Condorelli G; Drago R; Puglisi G
    Drug Dev Ind Pharm; 2006 Jun; 32(5):539-48. PubMed ID: 16720409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability profiles of M-alkoxysubstituted pyrrolidinoethylesters of phenylcarbamic acid across caco-2 monolayers and human skin.
    Gyürösiová L; Laitinen L; Raiman J; Cizmárik J; Sedlárová E; Hirvonen J
    Pharm Res; 2002 Feb; 19(2):162-8. PubMed ID: 11883643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention of barbituric acid derivatives on immobilized artificial membrane stationary phase and its correlation with biological activity.
    Kepczyńska E; Bojarski J; Haber P; Kaliszan R
    Biomed Chromatogr; 2000 Jun; 14(4):256-60. PubMed ID: 10861737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs.
    Salminen T; Pulli A; Taskinen J
    J Pharm Biomed Anal; 1997 Jan; 15(4):469-77. PubMed ID: 8953490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion of ketoprofen into the cerebrospinal fluid of young children.
    Kokki H; Karvinen M; Jekunen A
    Paediatr Anaesth; 2002 May; 12(4):313-6. PubMed ID: 11982837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of predictive retention-activity relationship models of non-steroidal anti-inflammatory drugs by micellar liquid chromatography: comparison with immobilized artificial membrane columns.
    Escuder-Gilabert L; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):59-70. PubMed ID: 10798294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.
    Grumetto L; Russo G; Barbato F
    Mol Pharm; 2016 Aug; 13(8):2808-16. PubMed ID: 27377191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.